Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Use of complementary and alternative medicine within Norwegian hospitals.

Jacobsen R, Fønnebø VM, Foss N, Kristoffersen AE.

BMC Complement Altern Med. 2015 Aug 13;15:275. doi: 10.1186/s12906-015-0782-5.

2.

[Re: A woman in her forties with cancer, syncope and spasms].

Fønnebø V.

Tidsskr Nor Laegeforen. 2015 Jan 27;135(2):104. doi: 10.4045/tidsskr.14.1600. eCollection 2015 Jan 27. Norwegian. No abstract available.

3.

V. Fønnebø svarer.

Fønnebø V.

Tidsskr Nor Laegeforen. 2014 Sep 2;134(16):1546. doi: 10.4045/tidsskr.14.0923. eCollection 2014 Sep 2. Norwegian. No abstract available.

PMID:
25178210
Free Article
4.

Mammography screening should be discontinued.

Fønnebø V.

Tidsskr Nor Laegeforen. 2014 Jun 17;134(11):1127. doi: 10.4045/tidsskr.14.0554. eCollection 2014 Jun 17. English, Norwegian. No abstract available.

5.

[A research roadmap for complementary and alternative medicine - what we need to know by 2020].

Fischer F, Lewith G, Witt CM, Linde K, von Ammon K, Cardini F, Falkenberg T, Fønnebø V, Johannessen H, Reiter B, Uehleke B, Weidenhammer W, Brinkhaus B.

Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24.

6.

High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research.

Fischer FH, Lewith G, Witt CM, Linde K, von Ammon K, Cardini F, Falkenberg T, Fønnebø V, Johannessen H, Reiter B, Uehleke B, Weidenhammer W, Brinkhaus B.

BMC Complement Altern Med. 2014 Feb 6;14:46. doi: 10.1186/1472-6882-14-46.

7.

Failure to account for selection-bias.

Kalager M, Løberg M, Fønnebø VM, Bretthauer M.

Int J Cancer. 2013 Dec 1;133(11):2751-3. doi: 10.1002/ijc.28244. Epub 2013 Jun 17. No abstract available.

PMID:
23649899
8.

Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use.

Kristoffersen AE, Norheim AJ, Fønnebø VM.

Evid Based Complement Alternat Med. 2013;2013:318781. doi: 10.1155/2013/318781. Epub 2013 Mar 28.

9.

A pilot feasibility study of a questionnaire to determine European Union-wide CAM use.

Eardley S, Bishop FL, Cardini F, Santos-Rey K, Jong MC, Ursoniu S, Dragan S, Hegyi G, Uehleke B, Vas J, Jupaneant O, Citro MC, Fønnebø V, Quandt SA, Lewith G.

Forsch Komplementmed. 2012;19(6):302-10. doi: 10.1159/000345839. Epub 2012 Dec 17.

PMID:
23343585
10.

Comparing attendees with non-attendees in breast screening does not provide useful information about an effect on prognostic features or mortality.

Jørgensen KJ, Kalager M, Zahl PH, Fønnebø VM.

Breast Cancer Res Treat. 2012 Nov;136(2):617-8, author reply 619-20. doi: 10.1007/s10549-012-2250-y. Epub 2012 Sep 26. No abstract available.

PMID:
23011508
11.

The NAFKAM International Registry of Exceptional Courses of Disease Related to the Use of Complementary and Alternative Medicine.

Fønnebø V, Drageset BJ, Salamonsen A.

Glob Adv Health Med. 2012 Mar;1(1):60-2. doi: 10.7453/gahmj.2012.1.1.012. Review.

12.

A Patient-defined "Best Case" of Multiple Sclerosis Related to the Use of Complementary and Alternative Medicine.

Salamonsen A, Drageset BJ, Fønnebø V.

Glob Adv Health Med. 2012 Mar;1(1):32-4. doi: 10.7453/gahmj.2012.1.1.009.

13.

Worst Cases Reported to the NAFKAM International Registry of Exceptional Courses of Disease.

Fønnebø V, Drageset BJ, Salamonsen A.

Glob Adv Health Med. 2012 Mar;1(1):30. doi: 10.7453/gahmj.2012.1.1.008. No abstract available.

14.

Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD.

Kristoffersen AE, Norheim AJ, Fønnebø VM.

BMC Complement Altern Med. 2012 Jan 12;12:1. doi: 10.1186/1472-6882-12-1.

15.

Key issues in clinical and epidemiological research in complementary and alternative medicine--a systematic literature review.

Fischer HF, Junne F, Witt C, von Ammon K, Cardini F, Fønnebø V, Johannessen H, Lewith G, Uehleke B, Weidenhammer W, Brinkhaus B.

Forsch Komplementmed. 2012;19 Suppl 2:51-60. doi: 10.1159/000343126. Review.

PMID:
23883945
16.

International development of traditional medicine / complementary and alternative medicine research--what can Europe learn?

Hök J, Lewith G, Weidenhammer W, Santos-Rey K, Fønnebø V, Wiesener S, Falkenberg T.

Forsch Komplementmed. 2012;19 Suppl 2:44-50. doi: 10.1159/000342724.

PMID:
23883944
17.

Legal status and regulation of complementary and alternative medicine in Europe.

Wiesener S, Falkenberg T, Hegyi G, Hök J, Roberti di Sarsina P, Fønnebø V.

Forsch Komplementmed. 2012;19 Suppl 2:29-36. doi: 10.1159/000343125. Review.

PMID:
23883942
18.

A systematic literature review of complementary and alternative medicine prevalence in EU.

Eardley S, Bishop FL, Prescott P, Cardini F, Brinkhaus B, Santos-Rey K, Vas J, von Ammon K, Hegyi G, Dragan S, Uehleke B, Fønnebø V, Lewith G.

Forsch Komplementmed. 2012;19 Suppl 2:18-28. doi: 10.1159/000342708. Review.

PMID:
23883941
19.

Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women.

Emaus N, Nguyen ND, Almaas B, Berntsen GK, Center JR, Christensen M, Gjesdal CG, Grimsgaard AS, Nguyen TV, Salomonsen L, Eisman JA, Fønnebø VM.

Eur J Nutr. 2013 Feb;52(1):49-55. doi: 10.1007/s00394-011-0285-1. Epub 2011 Nov 30.

PMID:
22127508
20.

Traditional Chinese medicine in cancer care: a review of case reports published in Chinese literature.

Liu J, Li X, Liu J, Ma L, Li X, Fønnebø V.

Forsch Komplementmed. 2011;18(5):257-63. doi: 10.1159/000333065. Epub 2011 Oct 4. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk